Dearth of training for vascular surgeons, high cost of varicose vein treatment procedures, and implementation of healthcare reforms in the U.S. are some of the key factors restraining the growth of market. In addition to this, challenges associated with inconsistent reimbursement scenario for varicose vein treatment procedures and sustainability of players in the highly competitive market also limits the growth of the market.

What the Market Looks Like?

The varicose vein treatment market is projected to reach to reach $289.7 million by 2021 from $207.9 million in 2016, growing at a CAGR of 6.9% from 2016 to 2021. This report covers the market across two major geographies, namely, North America and Europe.

Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market. Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107

Objectives of the study are :

• To define, describe, and forecast the market in North America and Europe on the basis of mode of treatment, products, and regions
• To provide detailed information regarding major factors influencing the growth of the market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To strategically profile the key players and comprehensively analyze their market shares
• To estimate and forecast the market by mode and product in North America (U.S. and Canada) and Europe (Germany, U.K., France, Italy, Spain, and Rest of Europe)

This report broadly segments the Varicose Vein Treatment market into mode of treatment and products. On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016.

Read more about Varicose Vein Treatment Modes Market @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=22524107

Dearth of training for vascular surgeons, high cost of varicose vein treatment procedures, and implementation of healthcare reforms in the U.S. are some of the key factors restraining the growth of market. In addition to this, challenges associated with inconsistent reimbursement scenario for varicose vein treatment procedures and sustainability of players in the highly competitive market also limits the growth of the market.

What the Market Looks Like?

The varicose vein treatment market is projected to reach to reach $289.7 million by 2021 from $207.9 million in 2016, growing at a CAGR of 6.9% from 2016 to 2021. This report covers the market across two major geographies, namely, North America and Europe.

Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market. Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107

Objectives of the study are :

• To define, describe, and forecast the market in North America and Europe on the basis of mode of treatment, products, and regions
• To provide detailed information regarding major factors influencing the growth of the market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To strategically profile the key players and comprehensively analyze their market shares
• To estimate and forecast the market by mode and product in North America (U.S. and Canada) and Europe (Germany, U.K., France, Italy, Spain, and Rest of Europe)

This report broadly segments the Varicose Vein Treatment market into mode of treatment and products. On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016. 

Read more about Varicose Vein Treatment Modes Market @   https://www.marketsandmarkets.com/requestsampleNew.asp?id=22524107  

Global Varicose Vein Treatment Market is anticipated to reach USD 475 million by 2024. Varicose veins literally known as “Veins on the leg”. They fall in the category of “varicose veins” if they get twisted. The factors that propel the growth of the Varicose Vein Treatment industry include reduced risk of collateral damage to adjacent tissues, painless technique, improved saturation, fewer post-operative complications, no requirement of anesthesia, less scarring, and minimal need for incisions during the procedure. On the other hand, there are factors that may hamper the growth of the market including shortage of trained vascular physicians and high price of varicose vein treatment methods.

Request a Free Sample Copy of Varicose Vein Treatment Market Report @ https://www.millioninsights.com/industry-reports/varicose-vein-treatment-market/request-sample 

Varicose Vein Treatment industry is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe. The market may be explored by treatment mode, product type, and geography. The industry may be explored by treatment mode as Surgical Ligation/Stripping, Endovenous Ablation, and Injection Sclerotherapy. The “Endovenous Ablation” sector led the Varicose Vein Treatment Market in 2016 and is anticipated to maintain its dominance by 2024.

The Varicose Vein Treatment industry could be explored based on product type as Venous Closure Products, Ablation Devices, Laser Ablation Devices, and Radiofrequency Ablation Devices. The “Radiofrequency Ablation Devices” sector led the Varicose Vein Treatment Market in 2016 and is anticipated to maintain its dominance by 2024.
North America accounted for the major share of the Varicose Vein Treatment Market Size in 2015 and will continue to lead in the forthcoming period. The factors that could be attributed to the growth include fast development in this market; which could be attributed to a number of aspects counting progressive health care infrastructure, high disposable income, increasing administration expenditure, continuous lifestyle-associated changes, rising health care consciousness, increasing occurrence of varicose veins, and rising consequence of esthetics.

Some of the key players that fuel the development of the Varicose Vein Treatment industry comprise AngioDynamics, Inc., Medtronic plc, Biolitec AG, Lumenis Ltd., Syneron Medical Ltd., Dornier MedTech GmbH, Energist Group, Quanta Systems S.p.A., Vascular Solutions, Inc., and Eufoton S.R.L. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Download Full Research Report on “Varicose Vein Treatment Market” @ https://www.millioninsights.com/industry-reports/varicose-vein-treatment-market

Market Segment:

Varicose Vein Treatment Outlook ByType (Revenue, USD Million, 2013 - 2024)
• Sclerotherapy
• Endovenous Ablation
• Laser Ablation
• Radiofrequency Ablation
• Stripping

Varicose Vein Treatment Regional Outlook (Revenue, USD Million, 2013 - 2024)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Rest of Europe
• Asia Pacific
• India
• Japan
• China
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• MEA
• South Africa
• Rest of MEA